$65.3 Million is the total value of Invenire Partners, LP's 26 reported holdings in Q3 2022. The portfolio turnover from Q2 2022 to Q3 2022 was 58.6% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| HROW | Sell | Harrow Health Inc | $5,477,293,000 | +46.4% | 453,794 | -11.7% | 8.38% | +68.6% |
| DHX | Buy | DHI Group Inc | $5,187,288,000 | +52.6% | 964,180 | +40.9% | 7.93% | +75.7% |
| TTI | Buy | Tetra Technologies Inc | $4,251,996,000 | -5.9% | 1,184,400 | +6.5% | 6.50% | +8.4% |
| APYX | Buy | Apyx Medical Corp | $4,246,242,000 | +25.4% | 945,711 | +63.6% | 6.49% | +44.4% |
| INFU | Buy | InfuSystem Holdings Inc | $3,262,484,000 | -15.4% | 466,736 | +16.5% | 4.99% | -2.6% |
| Sell | Arena Group Holdings Inc | $3,161,750,000 | -9.2% | 241,355 | -37.6% | 4.84% | +4.6% | |
| CTLP | Buy | Cantaloupe Inc | $3,091,266,000 | -21.3% | 888,295 | +26.6% | 4.73% | -9.4% |
| PAR | Buy | PAR Technology Corp | $2,969,802,000 | -18.8% | 100,569 | +3.1% | 4.54% | -6.5% |
| LLNW | New | Edgio Inc | $2,919,000,000 | – | 1,050,000 | +100.0% | 4.46% | – |
| MCS | Marcus Corp | $2,877,007,000 | -6.0% | 207,128 | 0.0% | 4.40% | +8.3% | |
| New | DocGo Inc | $2,728,992,000 | – | 275,100 | +100.0% | 4.17% | – | |
| DNOW | NOW Inc | $2,706,967,000 | +2.8% | 269,350 | 0.0% | 4.14% | +18.3% | |
| EVRI | Buy | Everi Holdings Inc | $2,505,990,000 | +37.2% | 154,500 | +37.9% | 3.83% | +58.0% |
| PRIM | Primoris Services Corp | $2,364,375,000 | -25.3% | 145,500 | 0.0% | 3.62% | -14.0% | |
| CRY | Buy | Artivion Inc | $2,344,689,000 | +8.5% | 169,414 | +48.1% | 3.58% | +25.0% |
| TTEC | TTEC Holdings Inc | $2,245,719,000 | -34.7% | 50,682 | 0.0% | 3.43% | -24.8% | |
| SQNS | Buy | Sequans Communications SA | $2,125,406,000 | +37.2% | 595,352 | +3.4% | 3.25% | +57.9% |
| CLAR | Sell | Clarus Corp | $2,116,002,000 | -37.1% | 157,090 | -11.3% | 3.24% | -27.5% |
| INVE | Buy | Identiv Inc | $2,018,024,000 | +46.3% | 160,927 | +35.1% | 3.09% | +68.4% |
| NOTV | New | Inotiv Inc | $1,600,750,000 | – | 95,000 | +100.0% | 2.45% | – |
| OPRX | New | Optimizerx Corp | $1,556,100,000 | – | 105,000 | +100.0% | 2.38% | – |
| SRTS | New | Sensus Healthcare Inc | $1,489,403,000 | – | 118,867 | +100.0% | 2.28% | – |
| SNCR | Synchronoss Technologies Inc | $1,390,310,000 | -0.9% | 1,219,571 | 0.0% | 2.13% | +14.2% | |
| BTTR | Better Choice Company Inc | $699,641,000 | -63.8% | 879,167 | 0.0% | 1.07% | -58.3% | |
| New | CLAR CORP | $58,500,000 | – | 300 | +100.0% | 0.09% | – | |
| New | CLAR CORP | $3,500,000 | – | 700 | +100.0% | 0.01% | – | |
| ASPN | Exit | Aspen Aerogels Inc | $0 | – | -24,494 | -100.0% | -0.32% | – |
| NDLS | Exit | Noodles & Co | $0 | – | -191,953 | -100.0% | -1.20% | – |
| CYRX | Exit | Cryoport Inc | $0 | – | -45,283 | -100.0% | -1.86% | – |
| MX | Exit | MagnaChip Semiconductor Corp | $0 | – | -115,000 | -100.0% | -2.22% | – |
| SHYF | Exit | Shyft Group Inc | $0 | – | -103,100 | -100.0% | -2.54% | – |
| CMCO | Exit | Columbus McKinnon Corp | $0 | – | -68,597 | -100.0% | -2.58% | – |
| Exit | Edgio Inc | $0 | – | -865,000 | -100.0% | -2.65% | – | |
| DLA | Exit | Delta Apparel Inc | $0 | – | -96,358 | -100.0% | -3.63% | – |
| UIS | Exit | Unisys Corp | $0 | – | -268,000 | -100.0% | -4.28% | – |
| NOA | Exit | North American Construction Group Ltd | $0 | – | -308,270 | -100.0% | -4.49% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| DHI Group Inc | 4 | Q3 2022 | 7.9% |
| Tetra Technologies Inc | 4 | Q3 2022 | 6.5% |
| Harrow Health Inc | 4 | Q3 2022 | 8.4% |
| TTEC Holdings Inc | 4 | Q3 2022 | 5.9% |
| Clarus Corp | 4 | Q3 2022 | 5.9% |
| Apyx Medical Corp | 4 | Q3 2022 | 6.5% |
| InfuSystem Holdings Inc | 4 | Q3 2022 | 5.1% |
| PAR Technology Corp | 4 | Q3 2022 | 4.9% |
| Cantaloupe Inc | 4 | Q3 2022 | 5.2% |
| Marcus Corp | 4 | Q3 2022 | 4.4% |
View Invenire Partners, LP's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G/A | 2023-03-31 |
| SC 13G | 2023-01-23 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-13 |
| 13F-HR | 2022-02-14 |
| D/A | 2019-03-12 |
| D | 2018-01-02 |
View Invenire Partners, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.